MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1

World Journal of Gastroenterology

Volumn 21, Issue 19, 2015, Pages 5867-5876

  Zang, Wen Qiao ^a   Yang, Xuan ^a   Wang, Tao ^b   Wang, Yuan Yuan ^a   Du, Yu Wen ^a   Chen, Xiao Nan ^a   Li, Min ^a   Zhao, Guo Qiang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cyclin dependent kinase inhibitor 2D; Esophageal squamous cell carcinoma; MAP3K1; MiR 451; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2D; LUCIFERASE; MICRORNA; MICRORNA 451; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; UNCLASSIFIED DRUG; CDKN2D PROTEIN, HUMAN; MAP3K1 PROTEIN, HUMAN; MIRN451 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; ESOPHAGEAL CANCER CELL LINE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOLECULARLY TARGETED THERAPY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR INVASION; CARCINOMA; ENZYMOLOGY; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P19; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE KINASE 1; MICRORNAS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84929643373     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i19.5867     Document Type: Article

References (30)

1. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009;24:729-735 [PMID: 19646015 DOI: 10.1111/j.1440-1746.2009.05824.x]
2. Dawsey SP, Tonui S, Parker RK, Fitzwater JW, Dawsey SM, White RE, Abnet CC. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS One 2010;5:e14080 [PMID: 21124934 DOI: 10.1371/journal.pone.0014080]
3. Baxi SH, Burmeister B, Harvey JA, Smithers M, Thomas J. Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imaging Radiat Oncol 2008;52:583-587 [PMID: 19178634 DOI: 10.1111/j.1440-1673.2008.02023.x]
4. Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010;82:138-144 [PMID: 20588024 DOI: 10.1159/000310918]
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866 [PMID: 17060945 DOI: 10.1038/nrc1997]
6. Esteller M. Cancer Epigenetics for the 21st Century: What's Next? Genes Cancer 2011;2:604-606 [PMID: 21941616 DOI: 10.1177/1947601911423096]
7. Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 2014;5:63-70 [PMID: 24891977 DOI: 10.4291/wjgp. v5.i2.63]
8. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-D157 [PMID: 21037258 DOI: 10.1093/nar/gkq1027]
9. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 2007;364:509-514 [PMID: 17964546 DOI: 10.1016/j.bbrc.2007.10.077]
10. Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood 2009;113:1794-1804 [PMID: 18849488 DOI: 10.1182/blood-2008-05-155812]
11. Patrick DM, Zhang CC, Tao Y, Yao H, Qi X, Schwartz RJ, Jun-Shen Huang L, Olson EN. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 2010;24:1614-1619 [PMID: 20679397 DOI: 10.1101/gad.1942810]
12. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008;76:582-588 [PMID: 18619946 DOI: 10.1016/j.bcp. 2008.06.007]
13. Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci 2013;58:706-714 [PMID: 23053883 DOI: 10.1007/s10620-012-2395-x]
14. Zang W, Wang Y, Du Y, Xuan X, Wang T, Li M, Ma Y, Li P, Chen X, Dong Z, Zhao G. Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma. Tumor Biol 2014;35:3295-3304 [PMID: 24272087 DOI: 10.1007/s13277-013-1432-5]
15. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999;18:5311-5317 [PMID: 10498883 DOI: 10.1038/sj.onc.1202998]
16. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87 [PMID: 11960696]
17. Felisiak-Golabek A, Dansonka-Mieszkowska A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A, Rembiszewska A, Kupryjanczyk J. p19 (INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients. Cancer Biol Ther 2013;14:973-981 [PMID: 24022213 DOI: 10.4161/cbt.25966]
18. Gluick T, Yuan Z, Libutti SK, Marx SJ. Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma. Endocr Relat Cancer 2013;20:L27-L29 [PMID: 24127162 DOI: 10.1530/ERC-13-0445]
19. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 2000;19:4146-4150 [PMID: 10962575 DOI: 10.1038/sj.onc.1203769]
20. Bartkova J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours. APMIS 2003;111:252-265; discussion 265-266 [PMID: 12760379 DOI: 10.1034/j.1600-0463.2003.1110129.x]
21. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869 [PMID: 11274345]
22. Uhlik MT, Abell AN, Cuevas BD, Nakamura K, Johnson GL. Wiring diagrams of MAPK regulation by MEKK1, 2, and 3. Biochem Cell Biol 2004;82:658-663 [PMID: 15674433 DOI: 10.1139/o04-114]
23. Cuevas BD, Abell AN, Johnson GL. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007;26:3159-3171 [PMID: 17496913 DOI: 10.1038/sj.onc.1210409]
24. Hagemann C, Blank JL. The ups and downs of MEK kinase interactions. Cell Signal 2001;13:863-875 [PMID: 11728826 DOI: 10.1016/S0898-6568 (01) 00220-0]
25. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 1993;260:315-319 [PMID: 8385802 DOI: 10.1126/science.8385802]
26. Pham TT, Angus SP, Johnson GL. MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis. Genes Cancer 2013;4:419-426 [PMID: 24386504 DOI: 10.1177/1947601913513950]
27. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355 [PMID: 15372042 DOI: 10.1038/nature02871]
28. Engels BM, Hutvagner G. Principles and effects of microRNAmediated post-transcriptional gene regulation. Oncogene 2006;25:6163-6169 [PMID: 17028595 DOI: 10.1038/sj.onc.1209909]
29. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005;433:769-773 [PMID: 15685193 DOI: 10.1038/nature03315]
30. Wurdinger T, Costa FF. Molecular therapy in the microRNA era. Pharmacogenomics J 2007;7:297-304 [PMID: 17189960 DOI: 10.1038/sj.tpj.6500429]